Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Mar 7, 2016

5262_dirs_2016-03-07_e4428aa6-bcb9-4565-9213-7d00c4ec8a56.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3000R

GlaxoSmithKline PLC

07 March 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 7 March 2016 of the following increases in the notional allocation of GSK American Depositary Shares (ADSs) on 1 March 2016, at a price of $39.66 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401(K) plan:

Director/PDMR Number of ADSs
Dr M M Slaoui 26
Connected Person Number of ADSs
Dr K Slaoui (Connected Person of Dr M M Slaoui) 9

V A Whyte

Company Secretary

7 March 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEDLFBQXFFBBB